Long-term treatment outcomes of depression with associated anxiety: Efficacy of continuation treatment with fluoxetine

Journal of Clinical Psychiatry

Volumn 65, Issue 3, 2004, Pages 373-378

  Joliat, Melissa J ^a   Schmidt, Mark E ^a   Fava, Maurizio ^b   Zhang, Shuyu ^a   Michelson, David ^a   Trapp, Nancy J ^a   Miner, Cherri M ^a  

^a ELI LILLY AND COMPANY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; META ANALYSIS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME;

ADULT; ANXIETY; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FLUOXETINE; HUMANS; MALE; QUESTIONNAIRES; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 2342473257     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v65n0313     Document Type: Article

References (25)

1. Zimmerman M, Chelminski I, McDermut W. Major depressive disorder and Axis I diagnostic comorbidity. J Clin Psychiatry 2002;63:187-193 (Pubitemid 34407076)
2. VanValkenburg C, Akiskal HS, Puzantian V, et al. Anxious depressions: clinical, family history, and naturalistic outcome: comparisons with panic and major depressive disorders. J Affect Disord 1984;6:67-82 (Pubitemid 14158974)
3. Bakish D. The patient with comorbid depression and anxiety: the unmet need. J Clin Psychiatry 1999;60(suppl 6):20-24 (Pubitemid 29210627)
4. Tollefson GD, Holman SL, Sayler ME, et al. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features. J Clin Psychiatry 1994;55:50-59 (Pubitemid 24081821)
5. Keller MB, Hanks DL. Anxiety symptom relief in depression treatment outcomes. J Clin Psychiatry 1995;56(suppl 6):22-29
6. Nutt DJ. Care of depressed patients with anxiety symptoms. J Clin Psychiatry 1999;60(suppl 17):23-27 (Pubitemid 29386036)
7. Shelton RC, Davidson J, Yonkers KA, et al. The undertreatment of dysthymia. J Clin Psychiatry 1997;58:59-65 (Pubitemid 27106795)
8. Clayton PJ, Grove WM, Coryell W, et al. Follow-up and family study of anxious depression. Am J Psychiatry 1991;148:1512-1517
9. Fava M, Uebelacker LA, Alpert JE, et al. Major depressive subtypes and treatment response. Biol Psychiatry 1997;42:568-576 (Pubitemid 27425475)
10. Flint AJ, Rifat SL. Anxious depression in elderly patients: response to antidepressant treatment. Am J Geriatr Psychiatry 1997;5:107-115 (Pubitemid 27157394)
11. Davidson JR, Meoni P, Haudiquet V, et al. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms. Depress Anxiety 2002;16:4-13 (Pubitemid 34977120)
12. Russell JM, Koran LM, Rush J, et al. Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression. Depress Anxiety 2001;13:18-27 (Pubitemid 32537090)
13. Bosworth HB, Hays JC, George LK, et al. Psychosocial and clinical predictors of unipolar depression outcome in older adults. Int J Geriatr Psychiatry 2002;17:238-246 (Pubitemid 34232596)
14. Clinical Practice Guideline Number 5: Depression in Primary Care, vol.2. Treatment of Major Depression. Rockville, Md: US Dept Health Human Services, Agency for Health Care Policy and Research; 1993. AHCPR publication 93-0551
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
16. Montgomery SA, Judge R. Treatment of depression with associated anxiety: comparisons of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand Suppl 2000;403:9-16 (Pubitemid 30691131)
17. Fava M, Rosenbaum JF, Hoog SL, et al. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression. J Affect Disord 2000;59:119-126 (Pubitemid 30317428)
18. Versiani M, Ontiveros A, Mazzotti G, et al. Fluoxetine versus amitriptyline in the treatment of major depression with associated anxiety (anxious depression): a double-blind comparison. Int Clin Psychopharmacol 1999;14:321-327 (Pubitemid 29531380)
19. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
20. Reimherr FW, Amsterdam JD, Quitkin FM, et al. Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment. Am J Psychiatry 1998;155:1247-1253 (Pubitemid 28402520)
21. Schmidt ME, Fava M, Robinson JM, et al. The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder. J Clin Psychiatry 2000;61:851-857 (Pubitemid 30947799)
22. Stewart JW, Quitkin FM, McGrath PJ, et al. Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo. Arch Gen Psychiatry 1998;55:334-343 (Pubitemid 28173623)
23. Ramana R, Paykel ES, Cooper Z, et al. Remission and relapse in major depression: a two-year prospective follow-up study. Psychol Med 1995;25:1161-1170
24. Lydiard RB, Brawman-Mintzer O. Anxious depression. J Clin Psychiatry 1998;59(suppl 18):10-17 (Pubitemid 28538508)
25. Flint AJ, Rifat SL. Two-year outcome of elderly patients with anxious depression. Psychiatry Res 1997;66:23-31 (Pubitemid 27111377)